WEC Energy Group Inc. Common Stock vs Zimmer Biomet Holdings Inc — how do they compare? WEC Energy Group Inc. Common Stock trades at $107 (market cap $34.50B), while Zimmer Biomet Holdings Inc trades at $92.24 (market cap $17.56B). The key difference: WEC Energy Group Inc. Common Stock is the larger of the two by market cap, and WEC Energy Group Inc. Common Stock pays the higher dividend (3.6%). Which is the better fit depends on your goals — on Pluang, investors hold WEC Energy Group Inc. Common Stock for 0 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| WEC | ZBH | |
|---|---|---|
Market Cap | $34.50B | $17.56B |
Volume | 2,835,735 | 2,298,426 |
Sector | Utilities | Health |
52-Week High | $118.85 | $103.98 |
52-Week Low | $100.78 | $79.58 |
Typical Hold Time | 0 Days | 89 Days |
Enterprise Value | $57.46B | $24.63B |
Dividend Yield | 3.6% | 1.04% |
Signals from Pluang's Aura AI — not financial advice
WEC Energy Group trades at $105.87, up 0.92% with neutral technical signals. The stock shows strong fundamentals with consistent earnings beats (Q2 2026 EPS of $0.91 vs. $0.804 expected) and improving profitability (net margin 16.7%). Recent news highlights growing data center demand as a key growth driver, with the company engaging in large-scale customer discussions for 400-500 megawatt projects.
WEC presents a compelling utility investment with stable cash flows and dividend potential, though faces interest rate sensitivity. Analyst consensus targets $118.33 (12% upside) with majority Hold ratings. Key risks include regulatory pressures and capital expenditure requirements for infrastructure expansion through 2030.
Zimmer Biomet (ZBH) trades at $91.77, down 0.43% on the day, with a bullish technical signal supported by moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.07 exceeding expectations. Revenue growth remains steady at $8.23B for 2025, though net income margins have moderated from 13.84% in 2023 to 8.56% in 2025. The company maintains strong profitability with a 69.87% gross margin and recently announced a $0.24 quarterly dividend.
ZBH presents a mixed outlook with positive earnings momentum and analyst consensus price target of $103.11 offering 12% upside potential. However, rising debt levels and competitive pressures in medical technology pose risks. Institutional ownership trends show continued interest, with State Street increasing its position by 0.6% in Q3 2026. The stock's valuation at 22.35 P/E appears reasonable given the company's market leadership position.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
WEC Energy Group is a Midwest electric and natural gas utility holding company whose subsidiaries, including We Energies and Wisconsin Public Service, deliver electricity and natural gas to customers in Wisconsin, Illinois, Michigan, and Minnesota.
Read more on WEC →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →